The primary responsibility of the ECOG-ACRIN Cancer Research Group’s Nominating Committee is to prepare the Principal Investigator (PI) Committee for the election of new Group Co-Chairs, as needed. In the unlikely event that the need arises for a Group Co-Chair to be recalled, the Nominating Committee also oversees this process.
The PI Committee holds a Nominating Committee election every two years from a slate of candidates proposed by the Executive Committee. This interaction between the two governance committees provides the Group with checks and balances within the election process. While the Executive and PI Committees both function under the direction of the Group Co-Chairs, the Nominating Committee is entirely independent in its role to nominate and elect new leaders (there are no appointments by the Group Co-Chairs). The Nominating Committee elects its own Chair every two years and the position is renewable.
The table below lists the current members of the Nominating Committee and the constituency they represent. These members were elected on October 8, 2024, and will serve a two-year term.
| Committee Member | Representation |
|---|---|
| Chair Thomas M. Habermann, MD Mayo Clinic Cancer Center | Academic Standing Members |
| Paul B. Gilman, MD Lankenau Medical Center | Academic Standing Members |
| Stanley R. Hamilton, MD City of Hope | Scientific Members |
| Barry A. Siegel, MD Washington University in St. Louis/Siteman Cancer Center | Scientific Members |
| Kurt R. Oettel, MD Wisconsin NCORP | Community Standing Members |
| Kathleen J. Yost, MD Cancer Research Consortium of West Michigan NCORP | Community Standing Members |
| Matthias Weiss, MD Wisconsin NCORP/ThedaCare | Affiliate and Sub-Affiliate Members |
| Angela M. DeMichele, MD, MSCE University of Pennsylvania/Abramson Cancer Center | Member at Large |
| Heather A. Wakelee, MD Stanford University/Stanford Cancer Institute | Member at Large |